NCT05372146

Brief Summary

86 patients were randomized into hot-CHIVA (n=43) and control (n=43) groups. Study group patients had undergone radiofrequency ablation (RFA) VNUS Closure - FastTM of one segment of GSV close to saphenofemoral junction. Controls had undergone whole refluxing trunk ablation. Additional phlebectomy was performed in all the patients of both groups. Primary end-point was change in quality of life (QoL) measured with CIVIQ-20 at 12 months. Secondary end-points was recurrence of varicose veins at 12 months. The investigators also measured GSV caliber at the median and distal thigh change in hot-CHIVA group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 27, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 3, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 12, 2022

Completed
Last Updated

May 19, 2022

Status Verified

November 1, 2019

Enrollment Period

10 months

First QC Date

May 3, 2022

Last Update Submit

May 12, 2022

Conditions

Keywords

varicose veinschivahemodynamic correction

Outcome Measures

Primary Outcomes (1)

  • Quality of life (QoL) was measured by ChronIc Venous Insufficiency Quality of Life (CIVIQ-20)

    There are 20 questions in the CIVIQ-20, each with 5 possible answers (1 to 5), the minimum possible score being 20 and the maximum 100. In order to calculate the GIS, the difference between the final score and the minimum possible score is to be divided by the difference between the theoretical maximum and minimum scores (100-20=80), multiplied by 100.

    12 months

Secondary Outcomes (3)

  • Varicose veins recurrence

    12 months

  • Leg discomfort related to CVD symptoms measured with 10-cm visual analogue scale (VAS) at 3 months

    2nd day, 7th day, 1 months, 3 months

  • In a study group remained GSV trunk diameter at mid- and lower thigh was measured at 1, 3, 6, 12 months after procedure

    1 months, 3 months, 6 months, 12 months

Study Arms (2)

CHIVA group

EXPERIMENTAL

43 participants. In the study group patients GSV was punctured 20-25 cm below SFJ. Radiofrequency catheter (ClosureFast) was inserted and positioned at SFJ distally to the superficial iliac circumflex vein. Four cycles were used for one segment below SFJ. After that catheter cooled down to 40C and was extracted. Phlebectomy was performed using Varady hooks after thermal ablation in both groups. All procedures were performed under tumescent anesthesia.

Procedure: GSV radiofrequency ablation with concomitant phlebectomy

Control group

ACTIVE COMPARATOR

43 participants. In the controls GSV was punctured at a distal part of a refluxing segment. Catheter was positioned at SFJ and conventional radiofrequency procedure was performed with four cycles below SFJ and two cycles for every next segment. Phlebectomy was performed using Varady hooks after thermal ablation in both groups. All procedures were performed under tumescent anesthesia.

Procedure: GSV radiofrequency ablation with concomitant phlebectomy

Interventions

Radiofrequency ablation with concomitant phlebectomy

CHIVA groupControl group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • C2EpAsPrGSVa, C2,3EpAsPrGSVa
  • Reflux not lower than upper part of the calf,
  • Age more than 18 years,
  • SFJ diameter less than 15mm,
  • Incompetence of terminal-femoral valve,
  • GSV reflux more than 0,5 sec,
  • re-entry perforator on the thigh or upper part of the calf for patients in the hot-CHIVA group

You may not qualify if:

  • C4-C6 class of CEAP
  • Pregnancy
  • Deep vein reflux more than 1 sec
  • SSV reflux more than 0,5 sec
  • Those unwilling to sign an informed consent were also included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Veronika Golovina

Moscow, 109044, Russia

Location

MeSH Terms

Conditions

Varicose Veins

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This was a single-center, prospective, non-randomized, non-inferiority comparative study conducted on patients with primary varicose veins
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2022

First Posted

May 12, 2022

Study Start

November 1, 2019

Primary Completion

September 1, 2020

Study Completion

February 27, 2022

Last Updated

May 19, 2022

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

Locations